A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of investigational allergology & clinical immunology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 24654314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations.

  2012cited by this paper
• Episode pattern and healthcare utilisation in patients with seasonal allergic rhinitis

  2012cited by this paper
• A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis.

  2012cited by this paper
• Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis.

  2012cited by this paper
• Treatment preferences in patients with moderate-severe seasonal allergic rhinitis: findings of a discrete choice experiment

  2012cited by this paper
• MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.

  2012cited by this paper
• Symptom Suppression in Subjects with Perennial Allergic Rhinitis Treated with Mometasone Furoate Nasal Spray

  2011cited by this paper
• How representative are clinical study patients with allergic rhinitis in primary care?

  2011cited by this paper
• Nonallergic rhinopathy (formerly known as vasomotor rhinitis).

  2011cited by this paper
• Fluticasone Furoate Nasal Spray is Effective and Well Tolerated for Perennial Allergic Rhinitis in Adolescents and Adults

  2010cited by this paper
• Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.

  2010cited by this paper
• Allergic rhinitis and the common cold – high cost to society

  2009cited by this paper
• Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis.

  2009cited by this paper
• Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents.

  2008cited by this paper
• Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis.

  2008cited by this paper
• Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis

  2008cited by this paper
• Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper

  2008cited by this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 *

  2008cited by this paper
• A survey of the burden of allergic rhinitis in Europe.

  2008cited by this paper
• A survey of the burden of allergic rhinitis in Europe

  2007cited by this paper
• A survey of the burden of allergic rhinitis in the USA

  2007cited by this paper
• Undertreatment of rhinitis symptoms in Europe: findings from a cross‐sectional questionnaire survey

  2007cited by this paper
• The burden of allergic rhinitis.

  2007cited by this paper
• Today’s allergic rhinitis patients are different: new factors that may play a role

  2007cited by this paper
• Allergic rhinitis: the impact of discordant perspectives of patient and physician on treatment decisions.

  2007cited by this paper
• Long‐term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis

  2007cited by this paper
• Keys to successful management of patients with allergic rhinitis: Focus on patient confidence, compliance, and satisfaction

  2007cited by this paper
• Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium

  2006cited by this paper
• Severity and impairment of allergic rhinitis in patients consulting in primary care.

  2006cited by this paper
• Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey.

  2005cited by this paper
• Quantitative and qualitative methods in UK health research: then, now and...?

  2002cited by this paper
• Local safety of intranasal triamcinolone acetonide: clinical and histological aspects of nasal mucosa in the long-term treatment of perennial allergic rhinitis.

  2001cited by this paper
• Update on nonallergic rhinitis.

  2001cited by this paper
• Assessment by Nasal Biopsy of Long-Term Use of Mometasone Furoate Aqueous Nasal Spray (Nasonex) in the Treatment of Perennial Rhinitis

  1998cited by this paper

• The latest investigational drugs for patients with allergic rhinitis

  2025influential citation
• In perennial allergic rhinitis, RQLQ is improved similarly by Azelastine 0.15 and mometasone furoate

  2025cites this paper
• Allergic rhinitis

  2024cites this paper
• Efficacy and safety of the combination nasal spray olopatadine hydrochloride-mometasone furoate in the treatment of allergic rhinitis

  2024cites this paper
• An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu® in Austrian Patients with Persistent Allergic Rhinitis

  2024cites this paper
• Nonallergic Rhinopathy: A Comprehensive Review of Classification, Diagnosis, and Treatment.

  2024cites this paper
• The Use of Azelastine Hydrochloride/Fluticasone Propionate in the Management of Allergic Rhinitis in Asia: A Review

  2024cites this paper
• V Brazilian Consensus on Rhinitis – 2024

  2024cites this paper
• Efficacy and safety of azelastine hydrochloride and fluticasone propionate nasal spray in treating allergic rhinitis: A randomized controlled trial

  2024cites this paper
• Intranasal combo: fixed-dose combination of mometasone furoate and olopatadine hydrochloride in therapeutic strategies for rhinosinusitis.

  2023cites this paper
• A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023.

  2023cites this paper
• The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers

  2023cites this paper
• A Review Regarding the Connections between Allergic Rhinitis and Asthma - Epidemiology, Diagnosis and Treatment

  2023cites this paper
• Real-Life Effectiveness of MP-AzeFlu (Dymista®) in Swedish Patients with Persistent Allergic Rhinitis, Assessed by the Visual Analogue Scale

  2023influential citation
• Diagnosis and Treatment in Asthma and Allergic Rhinitis: Past, Present, and Future

  2023cites this paper
• Surgical management of chronic rhinosinusitis with nasal polyps under local anaesthesia: indications and results

  2023cites this paper
• International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

  2023cites this paper
• Efficacy and safety of twice-daily olopatadine–mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis

  2021cites this paper
• Efficacy of a food supplement Lertal® as an adjuvant therapy of patients with moderate-to-severe seasonal allergic rhinoconjunctivitis

  2021cites this paper
• MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review

  2021cites this paper
• Prevalence, comorbidities, diagnosis, and treatment of nonallergic rhinitis: real-world comparison with allergic rhinitis

  2020cites this paper
• Intranasal antihistamine is superior to oral H1-antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis.

  2020cites this paper
• Tackling nasal symptoms in athletes: Moving towards personalized medicine

  2020cites this paper
• Recent Combination Therapy Options for Allergic Rhinitis

  2020cites this paper
• Rhinitis 2020: A Practice Parameter Update.

  2020cites this paper
• Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

  2020cites this paper
• Meta Analysis Study and Systemic Review of the Efficacy of Combination of H1 Antihistamine with Intranasal Corticosteroid in Management of Allergic Rhinitis

  2020cites this paper
• MP‐AzeFlu provides rapid and effective allergic rhinitis control: results of a non‐interventional study in Denmark

  2019cites this paper
• Efficacy of a Novel Intranasal Formulation of Azelastine Hydrochloride and Fluticasone Propionate, Delivered in a Single Spray, for the Treatment of Seasonal Allergic Rhinitis: Results from Russia

  2019cites this paper
• Intranasal corticosteroids for non-allergic rhinitis.

  2019cites this paper
• Intranasal Azelastine and Fluticasone as Combination Therapy for Allergic Rhinitis: Systematic Review and Meta-analysis

  2019cites this paper
• Diagnostic différentiel et pathologies mixtes

  2019cites this paper
• The complex pathophysiology of allergic rhinitis: scientific rationale for the development of an alternative treatment option

  2019cites this paper
• The Association of Industry Payments to Physicians with Prescription of Brand-Name Intranasal Corticosteroids

  2018cites this paper
• The Burden of Allergic Rhinitis: A Mini-Review

  2018cites this paper
• Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta‐analysis

  2018cites this paper
• Rapid onset of action and reduced nasal hyperreactivity: new targets in allergic rhinitis management

  2018cites this paper
• Safety of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate in children: A randomized clinical trial.

  2018cites this paper
• Chronic Nonallergic Rhinitis.

  2018cites this paper
• Real‐life effectiveness of MP‐AzeFlu in Irish patients with persistent allergic rhinitis, assessed by visual analogue scale and endoscopy

  2018cites this paper
• Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers

  2018cites this paper
• MP29‐02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite‐allergic rhinitis

  2018cites this paper
• Allergic rhinitis

  2018cites this paper
• 国际过敏与鼻科学共识声明 : 变应性鼻炎

  2018cites this paper
• MP-AzeFlu provides rapid and effective allergic rhinitis control: results of a non-interventional study in Romania.

  2018cites this paper
• Influence of MP 29-02 on ciliary beat frequency in human epithelial cells in vitro

  2018cites this paper
• Allergien im Hals-Nasen-Ohren-Bereich

  2018cites this paper
• International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

  2018cites this paper
• Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

  2017cites this paper
• BSACI guideline for the diagnosis and management of allergic and non‐allergic rhinitis (Revised Edition 2017; First edition 2007)

  2017cites this paper
• Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis.

  2017cites this paper
• University of Dundee An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK

  2017cites this paper
• A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu

  2017influential citation
• An algorithm recommendation for the pharmacological management of allergic rhinitis in the UK: a consensus statement from an expert panel

  2017cites this paper
• Non-Allergic Rhinitis

  2016cites this paper
• Antihistamines for the Treatment of Allergic Rhino-conjunctivitis

  2016cites this paper
• Treatment of idiopathic rhinitis with kinetic oscillations – a multi-centre randomized controlled study

  2016cites this paper
• An update regarding the treatment of nonallergic rhinitis

  2016cites this paper
• Effectiveness of allergic rhinitis treatments in real-life with a focus on MP-AzeFlu

  2016influential citation
• Safety evaluation of MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) for allergic rhinitis

  2016influential citation
• Recent pharmacological developments in the treatment of perennial and persistent allergic rhinitis

  2016cites this paper
• Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds?

  2016cites this paper
• Nonallergic Rhinitis: Treatment.

  2016cites this paper
• Non-allergic rhinitis in children: Epidemiological aspects, pathological features, diagnostic methodology and clinical management

  2016cites this paper
• MP‐AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children

  2016cites this paper
• Emerging drugs for the treatment of perennial allergic rhinitis

  2016cites this paper
• Efficacy of MP‐AzeFlu in children with seasonal allergic rhinitis: Importance of paediatric symptom assessment

  2016cites this paper
• A review of the clinical efficacy and safety of MP-AzeFlu, a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, in clinical studies conducted during different allergy seasons in the US

  2016influential citation
• MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study.

  2016cites this paper
• Rhinite allergique : Dymista®, une alternative thérapeutique

  2016cites this paper
• New Pharmacologic Strategies for Allergic Rhinitis

  2016cites this paper
• Concomitant corticosteroid nasal spray plus antihistamine (oral or local spray) for the symptomatic management of allergic rhinitis

  2016cites this paper
• The improved efficacy of a fixed‐dose combination of fluticasone furoate and levocabastine relative to the individual components in the treatment of allergic rhinitis

  2015cites this paper
• Escaping the trap of allergic rhinitis

  2015cites this paper
• Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps

  2015influential citation
• Real-life effectiveness of a new allergic rhinitis therapy (MP29-02*) in Sweden

  2015cites this paper
• Clinically relevant outcome measures of novel pharmacotherapy for nonallergic rhinitis

  2015cites this paper
• 360 degree perspective on allergic rhinitis management in Italy: a survey of GPs, pharmacists and patients

  2015cites this paper
• Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report

  2015cites this paper
• A role for the intranasal formulation of azelastine hydrochloride/fluticasone propionate in the treatment of allergic rhinitis.

  2015cites this paper
• Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study.

  2015cites this paper
• Azelastine hydrochloride/fluticasone propionate combined in a single nasal spray: a guide to its use in allergic rhinitis

  2015cites this paper
• The history of topical therapy in patients with nasal allergy

  2015cites this paper
• Azelastine hydrochloride/fluticasone propionate combined in a single nasal spray: a guide to its use in allergic rhinitis

  2015cites this paper
• The journey from unmet need in allergic rhinitis to rationale for, and clinical development of, a new treatment option, MP29-02

  2014cites this paper
• Clinical development of an advanced intranasal delivery system of azelastine hydrochloride and fluticasone propionate.

  2014cites this paper
• Intranasal Corticosteroids for Non-Allergic Rhinitis

  2013cites this paper
• MP29-02: a breakthrough for the treatment of allergic rhinitis

  2013cites this paper
• Treatment of Allergic Rhinitis.

  2010cites this paper
• Practice parameter Rhinitis 2020: A practice parameter update

  year unknowncites this paper
• B R I E F C O M M U N I C A T I O N S CARBOXYLIC ACIDS FROM HERBS OF Veronica austriaca ,

  year unknowncites this paper